您好,欢迎访问北京市农林科学院 机构知识库!

Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae

文献类型: 外文期刊

作者: Xu, Fuzhou 1 ; Chen, Xiaoling 2 ; Shi, Aihua 2 ; Yang, Bing 2 ; Wang, Jinluo 3 ; Li, Yongqing; Guo, Xin; Blackall, 1 ;

作者机构: 1.China Agr Univ, Key Lab Prevent Vet Med, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China

2.China Agr Univ, Key Lab Prevent Vet Med, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China; Beijing Acad Agr & Forestry Sci, Inst Anim Sci & Vet Med, Beijing 100089, Peoples R China; Queensland Dept Primary Ind & Fisheries, Anim Res Inst, Yeerongpilly, Qld 4105, Australia

3.China Agr Univ, Key Lab Prevent Vet Med, Minist Agr, Coll Vet Med, Beijing 100

关键词: Actinobacillus pleuropneumoniae;apxIA gene;mutant;immunogenicity

期刊名称:VETERINARY MICROBIOLOGY ( 影响因子:3.293; 五年影响因子:3.599 )

ISSN: 0378-1135

年卷期: 2006 年 118 卷 3-4 期

页码:

收录情况: SCI

摘要: Actinobacillus pleuropneumoniae is the aetiological agent of porcine pleuropneumonia, a highly contagious and often fatal disease. A candidate live vaccine strain, potentially capable of cross-serovar protection, was constructed by deleting the section of the apxIA gene coding for the C-terminal segment of ApxI toxin of the A. pleuropneumoniae serovar 10 reference strain (1313039) and inserting a chloramphenicol resistance gene cassette. The mutant strain (termed D13039A(-)Chl(Gamma)) produced an approximately 48 kDa protein corresponding to the N-terminus of the ApxI toxin, and exhibited no haemolytic activity and lower virulence in mice compared with the parental strain. The mutant was evaluated in a vaccination-challenge trial in which pigs were given two intra-nasal doses of the mutant at 14 days intervals and then challenged 14 days after the last vaccination with either A. pleuropneumoniae serovar 1 (4074) or serovar 2 (S1536) or serovar 10 (D13039) reference strains. The haemolysin neutralisation titres of the pre-challenge sera were significantly higher in the vaccinated pigs than in the unvaccinated pigs. The mortalities, clinical signs and lung lesion scores in the vaccinated pigs were significantly lower than those in the unvaccinated pigs for the serovar I challenge. A significantly lower lung lesion score was also observed in the vaccinated pigs, compared with unvaccinated pigs, for serovar 2 challenge. Our work suggests that the mutant strain offers potential as a live attenuated pleuropneumonia vaccine that can provide cross-serovar protection. (c) 2006 Elsevier B.V. All rights reserved.

  • 相关文献

[1]Identification and characterization of a novel adenine phosphoribosyltransferase gene (ZmAPT2) from maize (Zea mays L.). Wu, Suowei,Yu, Zhanwang,Li, Weihua,Yang, Qingkai,Ye, Chunjiang,Sun, Yan,Jin, Demin,Wang, Bin,Wu, Suowei,Li, Weihua,Yang, Qingkai,Wang, Fengge,Zhao, Jiuran.

[2]Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Yang YanMei,Fang RongXiang,Chen XiaoYing,Yang YanMei,Fang RongXiang,Chen XiaoYing,Yang YanMei,Li Xia,Yang Hui,Qian Yuan,Zhang You. 2011

[3]Efficacy Evaluation of an Inactivated Duck Tembusu Virus Vaccine. Lin, Jian,Liu, Yuehuan,Yang, Zhiyuan,Duan, Huijuan,Xie, Jia,Zhao, Jicheng,Pan, Jie,Wang, Xiuqing,Yang, Baoshou,He, Pingyou,Zou, Lihong.

作者其他论文 更多>>